nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical Experience with Endothelin Receptor Antagonists in Chronic Heart Failure
|
Alison Seed, MBChB MRCP |
|
2001 |
6 |
4 |
p. 317-323 7 p. |
artikel |
2 |
Clinical Experience with Endothelin Receptor Antagonists in Chronic Heart Failure
|
Seed, Alison |
|
2001 |
6 |
4 |
p. 317-323 |
artikel |
3 |
Crosstalk Between Endothelin and Nitric Oxide in the Control of Vascular Tone
|
Michel Lavallée, PhD |
|
2001 |
6 |
4 |
p. 265-276 12 p. |
artikel |
4 |
Crosstalk Between Endothelin and Nitric Oxide in the Control of Vascular Tone
|
Lavallée, Michel |
|
2001 |
6 |
4 |
p. 265-276 |
artikel |
5 |
Diagnostic and Therapeutic Potential of the Endothelin System in Patients with Chronic Heart Failure
|
Henry Krum, PhD FRACP |
|
2001 |
6 |
4 |
p. 341-352 12 p. |
artikel |
6 |
Diagnostic and Therapeutic Potential of the Endothelin System in Patients with Chronic Heart Failure
|
Krum, Henry |
|
2001 |
6 |
4 |
p. 341-352 |
artikel |
7 |
Editorial
|
Martine Clozel, MD |
|
2001 |
6 |
4 |
p. 249-251 3 p. |
artikel |
8 |
Editorial
|
Clozel, Martine |
|
2001 |
6 |
4 |
p. 249-251 |
artikel |
9 |
Endothelin and Heart Failure
|
Ponnal Nambi |
|
2001 |
6 |
4 |
p. 335-340 6 p. |
artikel |
10 |
Endothelin and Heart Failure
|
Nambi, Ponnal |
|
2001 |
6 |
4 |
p. 335-340 |
artikel |
11 |
Endothelin Antagonism in Experimental Ischemic Heart Failure: Hemodynamic, Structural and Neurohumoral Effects
|
Paul Mulder, PhD |
|
2001 |
6 |
4 |
p. 295-300 6 p. |
artikel |
12 |
Endothelin Antagonism in Experimental Ischemic Heart Failure: Hemodynamic, Structural and Neurohumoral Effects
|
Mulder, Paul |
|
2001 |
6 |
4 |
p. 295-300 |
artikel |
13 |
Endothelin A Receptor Antagonists in Congestive Heart Failure: Blocking the Beast while Leaving the Beauty Untouched?
|
Lukas E. Spieker |
|
2001 |
6 |
4 |
p. 301-315 15 p. |
artikel |
14 |
Endothelin A Receptor Antagonists in Congestive Heart Failure: Blocking the Beast while Leaving the Beauty Untouched?
|
Spieker, Lukas E. |
|
2001 |
6 |
4 |
p. 301-315 |
artikel |
15 |
Hemodynamic Effects of Bosentan in Patients with Chronic Heart Failure
|
W. Kiowski |
|
2001 |
6 |
4 |
p. 325-334 10 p. |
artikel |
16 |
Hemodynamic Effects of Bosentan in Patients with Chronic Heart Failure
|
Kiowski, W. |
|
2001 |
6 |
4 |
p. 325-334 |
artikel |
17 |
Potential Role of Endothelin Receptor Antagonists in the Setting of Cardiopulmonary Bypass: Relevance to Myocardial Performance
|
Adviye Ergul |
|
2001 |
6 |
4 |
p. 287-294 8 p. |
artikel |
18 |
Potential Role of Endothelin Receptor Antagonists in the Setting of Cardiopulmonary Bypass: Relevance to Myocardial Performance
|
Ergul, Adviye |
|
2001 |
6 |
4 |
p. 287-294 |
artikel |
19 |
Role of Endothelin in the Control of Peripheral Vascular Tone in Human Hypertension
|
Stefano Taddei |
|
2001 |
6 |
4 |
p. 277-285 9 p. |
artikel |
20 |
Role of Endothelin in the Control of Peripheral Vascular Tone in Human Hypertension
|
Taddei, Stefano |
|
2001 |
6 |
4 |
p. 277-285 |
artikel |
21 |
Therapeutic Role of Bosentan in Hypertension: Lessons from the Model of Perinephritic Hypertension
|
Julian E. Donckier, MD, PhD |
|
2001 |
6 |
4 |
p. 253-264 12 p. |
artikel |
22 |
Therapeutic Role of Bosentan in Hypertension: Lessons from the Model of Perinephritic Hypertension
|
Donckier, Julian E. |
|
2001 |
6 |
4 |
p. 253-264 |
artikel |